Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$375,000
$30.0 P/Share
|
|
Oct 06
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Oct 02
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
448
+3.79%
|
$12,096
$27.88 P/Share
|
|
Oct 02
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
448
+2.35%
|
$12,096
$27.88 P/Share
|
|
Oct 02
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
448
+2.35%
|
$12,096
$27.88 P/Share
|
|
Oct 02
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
448
+2.28%
|
$12,096
$27.88 P/Share
|
|
Oct 02
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
762
+2.34%
|
$20,574
$27.88 P/Share
|
|
Oct 02
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
224
+1.29%
|
$6,048
$27.88 P/Share
|
|
Sep 14
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-1.58%
|
$85,000
$34.86 P/Share
|
|
Sep 13
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$425,000
$34.9 P/Share
|
|
Sep 13
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Aug 25
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$412,500
$33.99 P/Share
|
|
Aug 25
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+1.36%
|
$87,500
$7.32 P/Share
|
|
Aug 21
2023
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
6,020
-24.85%
|
$192,640
$32.02 P/Share
|
|
Aug 21
2023
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,020
+19.9%
|
$36,120
$6.72 P/Share
|
|
Aug 11
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-1.38%
|
$400,000
$32.37 P/Share
|
|
Aug 11
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+1.35%
|
$100,000
$8.81 P/Share
|
|
Aug 10
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-1.56%
|
$77,500
$31.7 P/Share
|
|
Aug 01
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-1.39%
|
$400,000
$32.63 P/Share
|
|
Aug 01
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+1.36%
|
$112,500
$9.65 P/Share
|
|
Jul 13
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$437,500
$35.28 P/Share
|
|
Jul 13
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Jul 13
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-1.53%
|
$87,500
$35.37 P/Share
|
|
Jul 07
2023
|
Muna Bhanji Director |
SELL
Open market or private sale
|
Direct |
2,000
-12.48%
|
$68,000
$34.12 P/Share
|
|
Jul 03
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
187
+1.1%
|
$6,171
$33.36 P/Share
|
|
Jul 03
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
636
+2.01%
|
$20,988
$33.36 P/Share
|
|
Jul 03
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
374
+1.96%
|
$12,342
$33.36 P/Share
|
|
Jul 03
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
374
+2.01%
|
$12,342
$33.36 P/Share
|
|
Jul 03
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
374
+2.01%
|
$12,342
$33.36 P/Share
|
|
Jul 03
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$400,000
$32.6 P/Share
|
|
Jul 03
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Jul 03
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
374
+3.31%
|
$12,342
$33.36 P/Share
|
|
Jun 12
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$462,500
$37.06 P/Share
|
|
Jun 12
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Jun 08
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-1.51%
|
$95,000
$38.07 P/Share
|
|
May 31
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$462,500
$37.67 P/Share
|
|
May 31
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
May 16
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$462,500
$37.41 P/Share
|
|
May 16
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
May 15
2023
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
4,166
-14.08%
|
$154,142
$37.77 P/Share
|
|
May 15
2023
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+12.34%
|
$24,996
$6.78 P/Share
|
|
May 11
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
1,787
-1.07%
|
$69,693
$39.5 P/Share
|
|
May 10
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+21.9%
|
-
|
|
May 10
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+21.9%
|
-
|
|
May 10
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+23.07%
|
-
|
|
May 10
2023
|
B Lynne Parshall Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+25.0%
|
-
|
|
May 10
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+21.42%
|
-
|
|
May 10
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+14.12%
|
-
|
|
May 10
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+32.15%
|
-
|
|
May 10
2023
|
Santo J Costa Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+25.0%
|
-
|